PD-1 and PD-L1 inhibitors are a class of drugs used for cancer treatment. These drugs help boost the immune system's ability to recognize and destroy tumor cells by blocking interaction between programmed cell death protein 1 (PD-1) and its ligand PD-L1. The need for cancer treatment has been rising significantly owing to increasing prevalence of various cancer types globally. PD-1 and PD-L1 inhibitors offer promising alternatives to conventional cancer treatment options by improving ... Read more
